EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between Low Vitamin D Status, Serotonin, and Clinico-Biobehavioral Parameters in Alzheimer’s Disease

Anna-Lena Richter, Marlies Diepeveen-de Bruin, Michiel G J Balvers, Lisette C P G M De Groot, Peter Paul De Deyn, Sebastiaan Engelborghs, Renger F Witkamp, Yannick Vermeiren

Dementia and Geriatric Cognitive Disorders · 2023

DOI: 10.1159/000534492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders, 2023. Verfasst von Anna-Lena Richter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Nutrition and Health, Chair Group Nutritional Biology, Wageningen University and Research (WUR), Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Alzheimer Disease, Vitamin D Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Studies suggest a role of vitamin D in the progression and symptomatology of Alzheimer’s disease (AD), with few in vitro studies pointing to effects on serotonergic and amyloidogenic turnover. However, limited data exist in AD patients on the potential association with cognition and behavioral and psychological signs and symptoms of dementia (BPSD). In this retrospective cross-sectional study, we, therefore, explored potential correlations of serum 25-hydroxyvitamin D3 (25(OH)D3) concentrations, indicative of vitamin D status, with serum serotonin (5-hydroxytryptamine, 5-HT) levels, cognitive/BPSD scorings, and cerebrospinal fluid (CSF) biomarker levels.

Methods

Frozen serum samples of 25 well-characterized AD subjects as part of a previous BPSD cohort were analyzed, of which 15 had a neuropathologically confirmed diagnosis. Serum 25(OH)D3 levels were analyzed by means of LC-MS/MS, whereas 5-HT concentrations were quantified by competitive ELISA.

Results

Among AD patients, vitamin D deficiency was highly prevalent, defined as levels below 50 nmol/L. Regression analyses, adjusted for age, gender, and psychotropic medications, revealed that serum 25(OH)D3 and 5-HT levels were positively associated (p = 0.012). Furthermore, serum 25(OH)D3 concentrations correlated inversely with CSF amyloid-beta (Aβ1-42) levels (p = 0.006), and serum 5-HT levels correlated positively with aggressiveness (p = 0.001), frontal behavior (p = 0.001), depression (p = 0.004), and partly with cognitive performance (p < 0.005). Lastly, AD patients on cholinesterase inhibitors had higher serum 25(OH)D3 (p = 0.030) and lower serum 5-HT (p = 0.012) levels.

Conclusions

The molecular associations between low vitamin D status, serum 5-HT, and CSF Aβ1-42 levels are highly remarkable, warranting further mechanistic and intervention studies to disclose potential involvement in the clinico-biobehavioral pathophysiology of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseVitamin D DeficiencyHumansSerotoninChromatography, LiquidCross-Sectional StudiesRetrospective StudiesTandem Mass SpectrometryVitamin DCalcifediol

Stichwörter der Autor:innen

25-hydroxyvitamin D3Alzheimer’s diseaseAmyloid-beta peptide of 42 amino acidsBehavioral and psychological signs and symptoms of dementiaSerotonin

Substanzen

SerotoninVitamin DCalcifediol

Autor:innen und Institutionen

  • Division of Human Nutrition and Health, Chair Group Nutritional Biology, Wageningen University and Research (WUR), Wageningen, The Netherlands.
  • Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Department of Neurology and Memory Clinic, Middelheim General Hospital, Antwerp, Belgium.
  • Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, The Netherlands.
  • Neuroprotection and Neuromodulation (NEUR) Research Group, Center for Neurosciences (C4N), Vrije Universiteit Brussel, Brussels, Belgium.
  • Department of Neurology and Bru-BRAIN, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Zitieren

APA

Richter, A. L., Diepeveen-de Bruin, M., Balvers, M. G. J., De Groot, L. C. P. G. M., De Deyn, P. P., Engelborghs, S., Witkamp, R. F., & Vermeiren, Y. (2023). Association between Low Vitamin D Status, Serotonin, and Clinico-Biobehavioral Parameters in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000534492

Vancouver

Richter AL, Diepeveen-de Bruin M, Balvers MGJ, De Groot LCPGM, De Deyn PP, Engelborghs S, et al. Association between Low Vitamin D Status, Serotonin, and Clinico-Biobehavioral Parameters in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 2023. doi:10.1159/000534492

BibTeX
@article{Richter2023,
  author = {Richter, Anna-Lena and Diepeveen-de Bruin, Marlies and Balvers, Michiel G J and De Groot, Lisette C P G M and De Deyn, Peter Paul and Engelborghs, Sebastiaan and Witkamp, Renger F and Vermeiren, Yannick},
  title = {Association between Low Vitamin D Status, Serotonin, and Clinico-Biobehavioral Parameters in Alzheimer’s Disease},
  journal = {Dementia and Geriatric Cognitive Disorders},
  year = {2023},
  doi = {10.1159/000534492}
}
Kostenlos starten →